Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-035701

Chief Accounting Officer sold 24,000 shares at an average $8.13 ($195,183)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-10 Sale : show line 1 in the form −5,989 $8.00 $47,925 93,910 D
2022-11-11 Sale : show line 2 in the form −18,011 $8.18 $147,258 75,899 D
Open-market sales · 24,000 sh · avg $8.13 · $195,183
Loading xslF345X03/doc4.xml…